Live feed06:59:00·80dPRReleasevia QuantisnowBiogen to Acquire Apellis, Enhancing the Company's Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into NephrologyByQuantisnow·Wall Street's wire, on your screen.APLS· Apellis Pharmaceuticals Inc.BIIB· Biogen Inc.Health Care
